STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$31.12 USD
-0.08 (-0.26%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $31.13 +0.01 (0.03%) 4:56 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for STAAR Surgical Company falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 21.35 | 38.76 | 24.50 | 5.91 | 14.05 |
Depreciation/Amortization & Depletion | 2.52 | 3.36 | 3.64 | 3.10 | 3.70 |
Net Change from Assets/Liabilities | -40.84 | -28.88 | -2.39 | -2.76 | -1.25 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 31.57 | 22.48 | 18.21 | 14.71 | 9.29 |
Net Cash From Operating Activities | 14.59 | 35.72 | 43.96 | 20.95 | 25.80 |
Property & Equipment | -18.19 | -18.11 | -13.65 | -8.40 | -10.10 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 92.54 | -138.27 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 |
Net Cash from Investing Activities | 74.35 | -156.38 | -13.65 | -8.40 | -10.18 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.58 | 8.42 | 19.44 | 20.65 | 3.46 |
Issuance (Repayment) of Debt | -0.16 | -0.13 | -1.65 | -1.08 | -3.31 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.42 | 8.30 | 17.79 | 19.57 | 0.15 |
Effect of Exchange Rate Changes | 0.20 | -0.86 | -0.86 | 0.37 | 0.20 |
Net Change In Cash & Equivalents | 96.56 | -113.23 | 47.25 | 32.49 | 15.97 |
Cash at Beginning of Period | 86.48 | 199.71 | 152.45 | 119.97 | 104.00 |
Cash at End of Period | 183.04 | 86.48 | 199.71 | 152.45 | 119.97 |
Diluted Net EPS | 0.43 | 0.78 | 0.50 | 0.12 | 0.30 |
Fiscal Year End for STAAR Surgical Company falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 4.04 | -3.34 | 21.35 | 13.59 | 8.77 |
Depreciation/Amortization & Depletion | 2.47 | 1.12 | 2.52 | 1.74 | 0.75 |
Net Change from Assets/Liabilities | -12.69 | 16.82 | -40.84 | -61.29 | -39.41 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 17.44 | 7.08 | 31.57 | 28.59 | 18.49 |
Net Cash From Operating Activities | 11.27 | 21.68 | 14.59 | -17.38 | -11.40 |
Property & Equipment | -11.44 | -5.20 | -18.19 | -15.10 | -5.92 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 6.96 | 21.39 | 92.54 | 67.05 | 26.02 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.48 | 16.19 | 74.35 | 51.95 | 20.11 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.30 | 4.10 | 7.58 | 7.17 | 0.02 |
Issuance (Repayment) of Debt | -0.08 | -0.04 | -0.16 | -0.12 | -0.08 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 4.22 | 4.06 | 7.42 | 7.05 | -0.06 |
Effect of Exchange Rate Changes | -1.27 | -0.94 | 0.20 | -0.67 | -0.43 |
Net Change In Cash & Equivalents | 9.74 | 40.99 | 96.56 | 40.95 | 8.22 |
Cash at Beginning of Period | 183.04 | 183.04 | 86.48 | 86.48 | 86.48 |
Cash at End of Period | 192.78 | 224.02 | 183.04 | 127.43 | 94.70 |
Diluted Net EPS | 0.15 | -0.07 | 0.16 | 0.10 | 0.12 |